hidden
hidden

Adult Stem Cells to Aid Stroke Victims

Athersys, Inc., a Cleveland-based biopharmaceutical company, recently received approval from the Food and Drug Administration to conduct a study that uses adult stem cells to treat stroke victims. The stem cell therapy can be conducted up to a week after the occurrence of a stroke, and during this time, the stem cells can effectively protect injured brain nerves and treat inflammation. Researchers are investigating the promising possibility of adult stem cells to generate substantial and sustainable neurological improvements for ischemic stroke victims.

Athersys, Inc., a Cleveland-based biopharmaceutical company, recently received approval from the Food and Drug Administration to conduct a study that uses adult stem cells to treat stroke victims. The stem cell therapy can be conducted up to a week after the occurrence of a stroke, and during this time, the stem cells can effectively protect injured brain nerves and treat inflammation. Researchers are investigating the promising possibility of adult stem cells to generate substantial and sustainable neurological improvements for ischemic stroke victims.

View Full Story